EAM Investors, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$2,737,000
+2.0%
201,521
+11.6%
0.60%
+25.8%
Q4 2017$2,684,000
-42.1%
180,503
-23.3%
0.48%
-21.9%
Q3 2017$4,632,000
+44.4%
235,470
+5.5%
0.62%
+16.2%
Q2 2017$3,207,000
-34.8%
223,140
-41.3%
0.53%
-17.6%
Q4 2015$4,915,000
+110.8%
380,433
+57.6%
0.64%
+74.3%
Q3 2015$2,332,000241,4400.37%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders